Skip to main content


The latest from Within3

commercial success in pharma

Optimizing operations in pre-clinical studies, trial design and execution, and expanded indications show promising potential.

what is the invisible college

How a hidden network of experts can support your strategy with directional insights.

KOL engagement trends

What are the new best practices for engaging KOLs and building successful relationships?

Jason Smith provides his perspective on Daphne Koller’s eye-opening McKinsey interview.


What major trends and market forces point the way to pharma’s future?

What’s new in life science, and how should companies respond?

twitter's impact on pharma

Our analytics show how upheaval at the social media company may impact the life science industry.

What's the value of congress monitoring?

You may be using social monitoring year-round, but there’s value in targeting a specific congress.

top 10 life science articles

It’s here – the definitive list of our most-read blog posts, articles, and resources.

2022 year in review

Did 2022 unfold as planned? We check in on our predictions.